Insulin Lispro (Eli Lily) en es it fr

Insulin Lispro (Eli Lily) Brand names, Insulin Lispro (Eli Lily) Analogs

Insulin Lispro (Eli Lily) Brand Names Mixture

  • No information avaliable

Insulin Lispro (Eli Lily) Chemical_Formula

C257H387N65O76S6

Insulin Lispro (Eli Lily) RX_link

http://www.drugs.com/cons/Insulin_Lispro.html

Insulin Lispro (Eli Lily) fda sheet

Insulin Lispro (Eli Lily) msds (material safety sheet)

Insulin Lispro (Eli Lily) Synthesis Reference

No information avaliable

Insulin Lispro (Eli Lily) Molecular Weight

5808

Insulin Lispro (Eli Lily) Melting Point

81 oC (Khachidze, D.G. et al., J. Biol. Phys. Chem. 1:64-67 (2001))

Insulin Lispro (Eli Lily) H2O Solubility

No information avaliable

Insulin Lispro (Eli Lily) State

Liquid

Insulin Lispro (Eli Lily) LogP

0.218

Insulin Lispro (Eli Lily) Dosage Forms

Solution (Subcutaneous Injection and Infusion, IV Administration); Suspension

Insulin Lispro (Eli Lily) Indication

For treatment of diabetes (type I and II)

Insulin Lispro (Eli Lily) Pharmacology

Used in the treatment of type I and type II diabetes. The primary activity of insulin is the regulation of glucose metabolism. In muscle and other tissues (except the brain), insulin causes rapid transport of glucose and amino acids intracellularly. It also promotes anabolism, and inhibits protein catabolism. In the liver, insulin promotes the uptake and storage of glucose in the form of glycogen, inhibits gluconeogenesis, and promotes the conversion of excess glucose into fat.

Insulin Lispro (Eli Lily) Absorption

No information avaliable

Insulin Lispro (Eli Lily) side effects and Toxicity

No information avaliable

Insulin Lispro (Eli Lily) Patient Information

No information avaliable

Insulin Lispro (Eli Lily) Organisms Affected

Humans and other mammals